Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Lack of a key enzyme causes severe skin issues and death in mice.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The research helps in creating genetically modified animals to study hair growth.

Blocking mTORC1 activity could increase hair pigmentation and potentially reverse greying.

A genetic marker linked to a type of hair loss was found in most patients studied.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Genetic variations may affect how well finasteride works for BPH patients.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Human skin can make serotonin and melatonin.

More research needed to confirm finasteride as standard treatment for FFA.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.